← Back to all 50 compounds
#35Growth Hormone & Body Composition

Hexarelin acetate

ghrelin/growth-hormone-secretagogue receptor agonist

Evidence: other human studyReviewed 2026-07-25

Investigated uses

  • No adequately documented human investigated use for the exact catalog identity/formulation was identified; any vendor-promoted goals were excluded from evidence grading.

Mechanism and hypotheses

  • Hexarelin is a synthetic ghrelin/growth-hormone-secretagogue receptor agonist studied in humans for endocrine and cardiovascular effects.
  • Hypothesized: Performance and recovery uses are not approved and lack gray-vial equivalence data.

Human evidence

  • No qualifying controlled human efficacy study for the exact catalog identity/formulation was identified in this review. Limitations: This is a bounded search conclusion, not proof that no report exists; identity, language and indexing limitations may apply.

Safety highlights

  • Unknown or insufficiently characterized for the exact catalog product.
  • Identity, purity, sterility, endotoxin, aggregation, immunogenicity, concentration and route-specific risks are not adequately characterized.

Regulatory context

No FDA-approved product matching the exact catalog presentation was identified in this review.

Sources used for this entry